Search
Medical Inquiry
MSL Visit
Company Information
Requests
Grants & Sponsorships
Investigator Sponsored Studies
Report an Adverse Event
Report an Product Quality Complaint
Resources
Hypertension
Aprocitentan
Insomnia
Daridorexant
Congresses
Pipeline
Contact Us
Menu
Search
Medical Inquiry
MSL Visit
Company Information
Requests
Grants & Sponsorships
Investigator Sponsored Studies
Report an Adverse Event
Report an Product Quality Complaint
Resources
Hypertension
Aprocitentan
Insomnia
Daridorexant
Congresses
Pipeline
Contact Us
Clinical Practice Guidelines for Deprescribing or Switching Hypnotic Medications for Insomnia: Guidance from the Alliance for Sleep
For a video about this information, please watch the video narrated by 2 of the authors, Drs. Watson and Dr. McCall, titled
“Clinical Practice Guidelines for Deprescribing or Switching Hypnotic Medications for Insomnia: Guidance from the Alliance for Sleep”
For information about a retrospective observational analysis of patients with insomnia switching to daridorexant, please refer to the module,
“Use of Daridorexant Among Patients with Chronic Insomnia: A Retrospective Observational Analysis”
.
If you would like to request any additional information, please contact Idorsia Medical Information by completing the medical inquiry form found
here
.
Return to Insomnia Disease State Resources
US Consumer (e.g., patient)
US Healthcare Professional